Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,502.60
+8.40 (0.56%)
Mar 9, 2026, 3:30 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 381.22 billion as of March 9, 2026. Its market cap has increased by 2.64% in one year.
Market Cap
381.22B
Enterprise Value
395.84B
Revenue
95.06B
Ranking
n/a
PE Ratio
41.48
Stock Price
1,502.60
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 381.22B, an increase of 11,743.60%. That is a compound annual growth rate of 22.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 381.22B | 5.90% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 715.49B |
| Alkem Laboratories | 661.19B |
| Glenmark Pharmaceuticals | 599.51B |
| Laurus Labs | 554.00B |
| Ajanta Pharma | 373.66B |
| Gland Pharma | 274.98B |
| Emcure Pharmaceuticals | 268.42B |
| Wockhardt | 211.17B |